Kleiner Perkins Caufield & Byers
2750 Sand Hill Road
Menlo Park
California
94025
United States
Tel: 650-233-2750
Fax: 650-233-0300
Website: http://www.kpcb.com/
9 articles about Kleiner Perkins Caufield & Byers
-
Ribometrix closed on a Series A financing worth $30 million. The round was led by M Ventures, with participation of new investors Amgen Ventures, Pappas Capital and Illumina Ventures.
-
FLX Bio Announces First Patient Dosed With FLX475, a Best-in-Class CCR4 Inhibitor for the Treatment of Multiple Cancers
9/27/2018
FLX Bio, Inc., a clinical-stage, biopharmaceutical company, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers.
-
There is a new player in the southern California biotech industry. New venture firm Westlake Village BioPartners launched with a $320 million fund and a leadership well familiar with the ins and outs of the biotech and pharma world.
-
Kleiner Perkins Caufield & Byers Launches New $525 Million Venture Fund
5/18/2012
-
Nexus Dx, Stealthy San Diego Company with Kleiner Perkins and Bay City Ties, Raises $15 Million
10/2/2009
-
Valley Firms Buy $20 Million In Pennsylvania Vaccine Maker, Novavax, Inc.'s Stock
2/27/2006
-
Kleiner Perkins Caufield & Byers Launches Two Funds; $600M Technology And Life Science, $200M Pandemic And Bio Defense
2/17/2006
-
Kleiner Perkins Caufield & Byers Forms $600 Million KPCB XII Fund, Announces $100 Million Greentech Initiative
2/16/2006
-
Kleiner Perkins Caufield & Byers Forms $200 Million Pandemic And Bio Defense Fund
2/16/2006